Radiotherapy

News Radiotherapy

• Merck: Phase III Trial of Cilengitide Did Not Meet Primary Endpoint in Patients With Newly Diagnosed Glioblastoma

  Merck announced that the Phase III CENTRICa trial of the investigational integrin inhibitor cilengitide did not meet its primary endpoint of significantly increasing overall survival when added to the current standard chemoradiotherapy regimen (temozolomide and radiotherapy). CENTRIC includes patien more

• Moffitt researchers find potential new therapeutic target for treating non-small cell lung cancer

  Researchers at Moffitt Cancer Center have found a potential targeted therapy for patients with tobacco-associated non-small cell lung cancer. It is based on the newly identified oncogene IKBKE, which helps regulate immune response. The study appeared in the online issue of Oncogene. The IKBKE gene i more

• Enhanced treatment of brain tumors

  Glioblastoma is regarded as the most malignant form of brain tumor. In many cases, neurosurgeons are not able to remove such tumors completely because of the risk of destroying too much brain tissue in the process. Moreover, it is often impossible to identify all the fine extensions by which the tum more

Publications Radiotherapy

• Defining pseudoprogression in glioblastoma multiforme

  Background and purpose Pseudoprogression is a frequent phenomenon observed since the introduction of postoperative therapy with radiotherapy and temozolomide (RT/TMZ) in glioblastoma multiforme (GBM) patients. However, the criteria defining pseudoprogression, its incidence, the time of occurrenc more

• Epilepsy in glioblastoma patients: basic mechanisms and current problems in treatment

  Glioblastoma-related epilepsy requires paying careful attention to a combination of factors with an integrated approach. Major interrelated issues must be considered in the seizure care of glioblastoma patients. Seizure control frequently requires the administration of antiepileptic drugs simultaneo more

• Ion-pair strategy for enabling Amifostine oral absorption: rat in situ and in vivo experiments

  Publication date: Available online 2 May 2013Source:European Journal of Pharmaceutical Sciences Author(s): N. Samiei , V. Mangas-Sanjuan , I. González-Álvarez , M. Foroutan , A. Shafaati , A. Zarghi , M. Bermejo This study shows the effect of ion pair formation on intestinal absorption an more

Market studies Radiotherapy

• Breast Cancer Market Report: 2011 Edition

  Breast cancer is one of the most common types of cancer after lung cancer and the second leading cause of death in women. Globally, more than one million women are diagnosed with breast cancer annually. Breast cancer is mainly found in women compared to men. Though women of all ages are at risk of d more

• Huiheng Medical, Inc. (HHGM) - Financial and Strategic SWOT Analysis Review

  Huiheng Medical, Inc. (Huiheng Medical) is engaged in the design, development, manufacture and marketing of radiation therapy systems, which are used for the treatment of cancer. Its product portfolio includes the OPEN Stereotactic Gamma-ray Radiotherapy System, TOP Stereotactic Gamma-ray Radiothera more

• Shinva Medical Instrument Co., Ltd. (600587) - Financial and Strategic SWOT Analysis Review

  Shinva Medical Instrument Co., Ltd. (Shinva Medical) is a medical device company engaged in the manufacture and marketing of medical instruments and environmental protection equipment. The product portfolio of the company includes digital diagnosis equipment, surgical instrument, sterilizer, radioth more

Websites Radiotherapy